Cargando…
Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits
BACKGROUND: Probucol and statin are often prescribed for treating atherosclerosis. These two drugs exhibit different mechanisms but it is unknown whether they have the same anti-atherogenic properties. In the current study, we examined whether these two drugs at optimal doses could inhibit the initi...
Autores principales: | Niimi, Manabu, Keyamura, Yuka, Nozako, Masanori, Koyama, Takashi, Kohashi, Masayuki, Yasufuku, Reiko, Yoshikawa, Tomohiro, Fan, Jianglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228370/ https://www.ncbi.nlm.nih.gov/pubmed/24188322 http://dx.doi.org/10.1186/1476-511X-12-166 |
Ejemplares similares
-
Add-On Effect of Probucol in Atherosclerotic, Cholesterol-Fed Rabbits Treated with Atorvastatin
por: Keyamura, Yuka, et al.
Publicado: (2014) -
An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats
por: Nozako, Masanori, et al.
Publicado: (2015) -
Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits
por: Wang, Yanli, et al.
Publicado: (2015) -
Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014) -
Principles and Applications of Rabbit Models for Atherosclerosis Research
por: Fan, Jianglin, et al.
Publicado: (2018)